No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Times cited: 2
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
Times cited: 63
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
Times cited: 105